In Search of Expo 67. Pedaling stress relief. Pink Viagra.

The scholarly work of Concordia faculty and researchers informs and improves society on many issues that affect our daily lives. Visit the Research section to read news stories involving research at Concordia, or read the most recent items here:   

• As noted in yesterday's review, the New York Times writes about the exhibitions underway in Montreal museums to mark the 50th anniversary of Expo 67 and draws special attention to the exhibition, In Search of Expo 67. It is further noted that almost half of the artists participating in the show, on now at the Musée d'art contemporain (MAC) de Montréal, are Concordia alumni or faculty. Three former Concordia students are referenced in the New York Times article: Geronimo Inutiq (major in anthropology, with his multimedia installation, "Together/Again, Katimakainnarivugut", pictured); Cheryl Sim (MA 10) and Charles Stankievech (MFA 07). In Search of Expo 67was co-curated by Monika Kin Gagnon, professor of communication studies in the Faculty of Arts and Science and co-director of the CinemaExpo67 research team at Concordia University. 
• There is continuing coverage of a new study from Concordia on the benefits of cycling. Researchers Stéphane Brutus, professor of management and RBC Professor of Motivation and Employee Performance, associate professor of management Alexandra Panaccio and JMSB research assistant Roshan Javadian (MSc 14,) describe how employees who ride their bike to work report lower stress levels. The study was published in the International Journal of Workplace Health Management: Time, True Viral News, Réseau d'Information Municipale du Québec(behind a paywall), Allo Med'Actu (France), Net Doctor (UK), NL Express (in Dutch, linked by HR netwerk), MSN Lifestyle, Hindustan Times.
• The National Post, reporting on a plan by Valeant Pharmaceuticals to re-launch Addyi, dubbed by some the "pink Viagra" for women, references the early work of Jim Pfaus, professor of psychology in the Faculty of Arts and Science, on flibanserin (Addyi) and notes that Pfaus has received consulting grants from Boehringer Ingelheim, Addyi’s original developer. Pfaus is quoted. The article is reprised by India Live Today. and Science.

 More Researchers in the news